Chelsea Ciaverelli Scott

Happy Monday! 🚀 Q4 Outlook: Life Sciences Staffing in NorCal 🚀 - As we enter Q4 2025, Northern California’s life sciences sector shows both resilience and new challenges: 📊 Key Highlights - California employs over 141,000 people in biomanufacturing, making it a cornerstone of the state’s 452,000+ life sciences workforce. - Bay Area lab/R&D vacancy has reached ~15.9%, the highest in years, as new space comes online faster than it’s being leased. - Employers are increasingly selective in hiring, with specialized R&D and regulatory roles still highly competitive. 🔍 What This Means for Employers - Talent pools are deeper, but securing the right expertise quickly is more critical than ever. 💬 Question for Leaders: - How is your team adapting hiring strategies as we close out 2025?

7

The introduction of RxBenefits, Inc. transparent PBM model is a shift toward accountability and cost efficiency in market access as it enables measurable savings and stronger alignment between industry stakeholders and patient outcomes. For pharmaceutical and biotech companies, this model may enhance formulary clarity, reduce administrative hurdles, and foster fairer pricing strategies, thereby streamlining patient access to innovative therapies. https://lnkd.in/e43NX823

16

California’s New PBM Law (SB 41) Takes Effect, Reshaping PBM Accountability A comprehensive pharmacy benefit manager (PBM) reform law in California, Senate Bill 41 (SB 41), took effect on January 1, 2026, imposing fiduciary duties on PBMs, requiring spread‑pricing prohibitions, rebate pass‑through to payers, and enhanced transparency and conflict disclosures. The law is already affecting major PBM contracts such as the California Public Employees’ Retirement System’s agreement with CVS Caremark, which now includes performance guarantees tied to cost and quality targets. https://buff.ly/OgEBr2b

2

✨Hiring Market Monday✨ SoCal Reflections, Mid-2025 edition! As we hit the halfway mark of 2025, the healthcare hiring landscape in Southern California continues to evolve—quietly but powerfully. 🌀 What we’re seeing: - Administrative and operational roles are in steady demand, especially in revenue cycle, compliance, and patient experience. - Workforce flexibility is no longer a perk—it’s an expectation. Hybrid and remote options are shaping candidate decisions. - Diversity, equity, and inclusion remain front and center—not just in hiring goals, but in how teams are built and supported. - Technology fluency is now a baseline requirement, even in traditionally non-technical roles. 💭 What it means: This isn’t just a hiring cycle—it’s a recalibration. Candidates are more intentional. Employers are more strategic. And the space between the two? That’s where the magic (and the challenge) lives. Here’s to building teams that are not only skilled, but sustainable. #HiringMarketMoonday #HealthcareHiring #SoCalJobs #WorkforceTrends #RecruitmentReflections #DEI #Hiring2025

5

We're currently in a labor market that remains steady - BUT intensely competitive, especially for specialized talent. Where's the strongest momentum? 💼 Finance & Accounting (Across the Bay Area) Seasonal peaks, IPO readiness, and cost‑management strategies are boosting demand for contract and project‑based F&A teams. 🏥 Healthcare & Life Sciences (Peninsula + South Bay) Biotech stability, clinical expansion, and ongoing provider shortages continue to drive strong hiring across research, clinical operations, and patient‑facing roles. 🏭 Industrial & Advanced Manufacturing (East Bay + North Bay) Reshoring, EV supply‑chain investment, and clean‑tech manufacturing are fueling increased demand for skilled labor, technicians, and engineering‑adjacent roles. 💻 Technology & Engineering (SF + Silicon Valley) AI adoption, cybersecurity spend, digital transformation, and clean‑energy innovation are driving above‑average hiring — with specialized engineering and data talent remaining extremely competitive. Even with signs of broader cooling, Bay Area specialized talent remains one of the most competitive markets in the country 🚀. Organizations are leaning more heavily on flexible workforce models to stay agile and scale smartly. If you're navigating hiring challenges or evaluating how these trends could shape your Bay Area talent strategy in 2026, DM me - happy to talk through what this means for your team.

2

Amgen is set to invest $600 million in a new research center at its Thousand Oaks campus 🚀. - Founded in 1980 right in Thousand Oaks, Amgen continues to be a pioneer in biotechnology. - The new research facility will enhance Amgen's existing R&D operations with advanced automation and digital capabilities. - Hundreds of new jobs will be created, providing a significant economic boost to Ventura County. - Amgen's CEO, Robert A. Bradway, emphasized that this new center will empower scientists to advance critical medicines for human health. - Construction is expected to start in the third quarter of this year, replacing an existing building on the property. With operations spread across the globe, including significant investments in North Carolina and Ohio, Amgen demonstrates a steadfast commitment to innovation and growth. #Biotech #Innovation #EconomicDevelopment

3

2 Comments

Reposting this exciting update from our IT leadership. It’s inspiring to see how IEHP continues to expand its focus on data, analytics, and AI to advance smarter, more personalized healthcare. Grateful to be part of an organization investing in innovation and the talented professionals who make it possible.

5

💚 Biostatistics is now a strategic engine for innovation, shaping trials, surfacing safety signals sooner, and translating massive health data into patient-centred insight. In a market that’s growing fast, it’s the difference between more data and better outcomes. Read the full blog post 👉 https://lnkd.in/dYcU4Qup #Akkodis #Biostatistics #Innovation #Safety

1

ManpowerGroup's Greg Coir shares timely insights in this new BioSpace feature exploring how pharma is responding to industry challenges with increased investment in AI. With 85% of companies ramping up AI efforts, Greg highlights how strategic innovation and adaptability are driving meaningful change in the life sciences space. #AIinPharma #LifeSciences #Leadership #Innovation #BioSpace

1

Abbott / Exact Sciences: the quiet bet on Diagnostic Engineering talent Abbott's ~$21 billion acquisition of Exact Sciences (EV ≈ $23B) is more than a diagnostics headline, it’s a strong signal that cancer‑screening and precision #oncology #CAPEX is going to surge. Every new diagnostics‑site roadmap now demands: - Modular, lab‑optimized platforms for liquid biopsy & stool‑based tests - Embedded automation, PAT, and real‑time analytics for MRD (molecular residual disease) workflows - Engineering & CAPEX leaders who understand genomics‑grade manufacturing, not just classical pharma For hiring managers, the pressing question isn’t just what to build ➡️ it's 𝑤ℎ𝑜 can design, deliver, and scale these next‑gen cancer‑diagnostic facilities. I work with life‑science clients daily to help Engineering & CAPEX leaders secure the people who can make these programs a reality. If your upcoming project already has skill gaps, #now is the time to act. 👉 Let’s discuss how to bridge those gaps before they slow your project. #headcountag #engineering #lifesciences #diagnostics

31

3 Comments